Cargando…

Quercetin prevents small intestinal damage and enhances intestinal recovery during methotrexate-induced intestinal mucositis of rats

BACKGROUND: Gastrointestinal mucositis occurs as a consequence of cytotoxic treatment. Quercetin (QCT) is a bioflavonoid that exerts significant antioxidant activity and anti-inflammatory as well as anti-malignancy properties. OBJECTIVE: To evaluate the effects of oral QCT consumption in preventing...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukhotnik, Igor, Moati, Dalia, Shaoul, Ron, Loberman, Boaz, Pollak, Yulia, Schwartz, Betty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Academia 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883860/
https://www.ncbi.nlm.nih.gov/pubmed/30026677
http://dx.doi.org/10.29219/fnr.v62.1327
_version_ 1783311734377807872
author Sukhotnik, Igor
Moati, Dalia
Shaoul, Ron
Loberman, Boaz
Pollak, Yulia
Schwartz, Betty
author_facet Sukhotnik, Igor
Moati, Dalia
Shaoul, Ron
Loberman, Boaz
Pollak, Yulia
Schwartz, Betty
author_sort Sukhotnik, Igor
collection PubMed
description BACKGROUND: Gastrointestinal mucositis occurs as a consequence of cytotoxic treatment. Quercetin (QCT) is a bioflavonoid that exerts significant antioxidant activity and anti-inflammatory as well as anti-malignancy properties. OBJECTIVE: To evaluate the effects of oral QCT consumption in preventing intestinal mucosal damage and stimulating intestinal recovery following methotrexate (MTX)-induced intestinal damage in a rat model. DESIGN: Male Sprague–Dawley rats were divided into four groups: Control Group A (CONTR) – rats were treated with 2 cc of saline given by gavage for 6 days. Group B (CONTR-QCT) – rats were treated with QCT (100 mg/kg in 2 ml saline) given by gavage 3 days before and 3 days after intraperitoneal (IP) injection of saline. Group C (MTX) – rats were injected a single dose (25 mg/kg) of MTX IP. Group D (MTX-QCT) rats were treated with QCT (similar to Group B) 3 days before and 3 days after IP MTX injection. Intestinal mucosal parameters (bowel and mucosal weight, mucosal DNA and protein content, and villus height and crypt depth), enterocytes proliferation, and enterocyte apoptosis degree were investigated at sacrifice on the 4th day after MTX or saline injection. RESULTS: Administration of QCT to MTX-treated rats resulted in: (1) significant decrease in intestinal injury score, (2) significant increase in intestinal and mucosal weight in jejunum and ileum, (3) increase on the protein content of the ileum, (4) increase in the villus height in the ileum, (5) increase of crypt depth of jejunum and ileum, and (6) increase in cell proliferation in the jejunum and ileum compared to MTX-nontreated group. CONCLUSIONS: Administration of QCT prevents intestinal damage and improves intestinal recovery following MTX-induced intestinal damage in a rat. We surmise that the effect of QCT is based on induction of cell proliferation in the crypt rather than inhibition of apoptosis.
format Online
Article
Text
id pubmed-5883860
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Open Academia
record_format MEDLINE/PubMed
spelling pubmed-58838602018-07-19 Quercetin prevents small intestinal damage and enhances intestinal recovery during methotrexate-induced intestinal mucositis of rats Sukhotnik, Igor Moati, Dalia Shaoul, Ron Loberman, Boaz Pollak, Yulia Schwartz, Betty Food Nutr Res Original Article BACKGROUND: Gastrointestinal mucositis occurs as a consequence of cytotoxic treatment. Quercetin (QCT) is a bioflavonoid that exerts significant antioxidant activity and anti-inflammatory as well as anti-malignancy properties. OBJECTIVE: To evaluate the effects of oral QCT consumption in preventing intestinal mucosal damage and stimulating intestinal recovery following methotrexate (MTX)-induced intestinal damage in a rat model. DESIGN: Male Sprague–Dawley rats were divided into four groups: Control Group A (CONTR) – rats were treated with 2 cc of saline given by gavage for 6 days. Group B (CONTR-QCT) – rats were treated with QCT (100 mg/kg in 2 ml saline) given by gavage 3 days before and 3 days after intraperitoneal (IP) injection of saline. Group C (MTX) – rats were injected a single dose (25 mg/kg) of MTX IP. Group D (MTX-QCT) rats were treated with QCT (similar to Group B) 3 days before and 3 days after IP MTX injection. Intestinal mucosal parameters (bowel and mucosal weight, mucosal DNA and protein content, and villus height and crypt depth), enterocytes proliferation, and enterocyte apoptosis degree were investigated at sacrifice on the 4th day after MTX or saline injection. RESULTS: Administration of QCT to MTX-treated rats resulted in: (1) significant decrease in intestinal injury score, (2) significant increase in intestinal and mucosal weight in jejunum and ileum, (3) increase on the protein content of the ileum, (4) increase in the villus height in the ileum, (5) increase of crypt depth of jejunum and ileum, and (6) increase in cell proliferation in the jejunum and ileum compared to MTX-nontreated group. CONCLUSIONS: Administration of QCT prevents intestinal damage and improves intestinal recovery following MTX-induced intestinal damage in a rat. We surmise that the effect of QCT is based on induction of cell proliferation in the crypt rather than inhibition of apoptosis. Open Academia 2018-03-28 /pmc/articles/PMC5883860/ /pubmed/30026677 http://dx.doi.org/10.29219/fnr.v62.1327 Text en © 2018 Igor Sukhotnik et al. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.
spellingShingle Original Article
Sukhotnik, Igor
Moati, Dalia
Shaoul, Ron
Loberman, Boaz
Pollak, Yulia
Schwartz, Betty
Quercetin prevents small intestinal damage and enhances intestinal recovery during methotrexate-induced intestinal mucositis of rats
title Quercetin prevents small intestinal damage and enhances intestinal recovery during methotrexate-induced intestinal mucositis of rats
title_full Quercetin prevents small intestinal damage and enhances intestinal recovery during methotrexate-induced intestinal mucositis of rats
title_fullStr Quercetin prevents small intestinal damage and enhances intestinal recovery during methotrexate-induced intestinal mucositis of rats
title_full_unstemmed Quercetin prevents small intestinal damage and enhances intestinal recovery during methotrexate-induced intestinal mucositis of rats
title_short Quercetin prevents small intestinal damage and enhances intestinal recovery during methotrexate-induced intestinal mucositis of rats
title_sort quercetin prevents small intestinal damage and enhances intestinal recovery during methotrexate-induced intestinal mucositis of rats
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883860/
https://www.ncbi.nlm.nih.gov/pubmed/30026677
http://dx.doi.org/10.29219/fnr.v62.1327
work_keys_str_mv AT sukhotnikigor quercetinpreventssmallintestinaldamageandenhancesintestinalrecoveryduringmethotrexateinducedintestinalmucositisofrats
AT moatidalia quercetinpreventssmallintestinaldamageandenhancesintestinalrecoveryduringmethotrexateinducedintestinalmucositisofrats
AT shaoulron quercetinpreventssmallintestinaldamageandenhancesintestinalrecoveryduringmethotrexateinducedintestinalmucositisofrats
AT lobermanboaz quercetinpreventssmallintestinaldamageandenhancesintestinalrecoveryduringmethotrexateinducedintestinalmucositisofrats
AT pollakyulia quercetinpreventssmallintestinaldamageandenhancesintestinalrecoveryduringmethotrexateinducedintestinalmucositisofrats
AT schwartzbetty quercetinpreventssmallintestinaldamageandenhancesintestinalrecoveryduringmethotrexateinducedintestinalmucositisofrats